Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Epicore BioNetworks is a biotechnology company specializing in the development and manufacture of microbial and enzyme-based products for aquaculture, agriculture, and environmental remediation. Founded in 1987 and headquartered in Eastampton, New Jersey, the company provides probiotics, specialty feeds, and water treatment solutions designed to improve animal health and environmental sustainability. Its core offerings include the EPICIN line of probiotics for water quality and the EPIFEED range of larval hatchery feeds. The company's technology platform leverages natural microbes to detoxify water and enhance nutrition in industrial settings. Following its acquisition by Neovia in 2017 and subsequently by ADM in 2019, Epicore operates as a key part of ADM's animal nutrition and biotechnology portfolio. It maintains a strong commercial presence in major aquaculture markets, particularly in Latin America and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Epicore BioNetworks.